L27.0
Generalized skin eruption due to drugs and medicaments taken internally
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Medical Intelligence & Overview
ICD-10 code L27.0 refers to a condition characterized by widespread skin eruptions resulting from the use of medications taken internally. This type of skin reaction can vary from mild to severe, affecting your skin's appearance and comfort. Recognizing the symptoms and causes can help in managing the condition effectively, often with the guidance of a healthcare professional.
Causes & Symptoms
Clinical Causes: Use of certain medications such as antibiotics, anticonvulsants, or non-steroidal anti-inflammatory drugs (NSAIDs). Allergic reactions to specific drugs that the body perceives as harmful. Discontinued or changed medication after long-term use or during initial therapy. Combination of multiple medications that may interact and cause skin reactions. Sensitivity to ingredients or preservatives present in medications.
Key Symptoms: Widespread, often symmetrical skin rashes or eruptions. Redness and inflammation across large areas of the skin. Presence of hives or raised, itchy bumps. Swelling of the skin, sometimes accompanied by blistering or peeling. Itching or discomfort in affected areas. In severe cases, symptoms may include fever, malaise, or general feeling of unwellness.
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves a detailed medical history review, including recent medication use. Physical examination helps identify the characteristic skin changes. In some cases, allergy testing or skin biopsies may be recommended to confirm the allergy or rule out other skin conditions. A healthcare provider may also review the timeline between medication intake and onset of symptoms to establish a connection.
Treatment Protocols: Managing drug-induced skin eruptions typically requires discontinuing the suspected medication under medical supervision. Supportive care may include the use of antihistamines to reduce itching and inflammation, topical corticosteroids for skin inflammation, and wound care for blistered or damaged skin. In more severe cases, systemic corticosteroids or other medications might be necessary. Identifying and avoiding the offending drug is crucial to prevent recurrence. Follow-up with a healthcare provider ensures symptoms are controlled and that any complications are addressed promptly.
Clinical Advice & FAQs
Billing Guidance
Is L27.0 a billable ICD-10 code?
Yes, L27.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L27.0?
Clinical documentation must specify the nature of Generalized skin eruption due to drugs and medicaments taken internally and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
